Apical hypertrophic cardiomyopathy: correlations between echocardiographic parameters, angiographic left ventricular

Chao-Chin Chen1, Meng-Huan Lei, Yu-Cheng Hsu

  • 1Division of Cardiology, Department of Medicine, Lo-Tung Poh-Ai Hospital, I-Lan, Taiwan. chen.stpaul@msa.hinet.net

Clinical Cardiology
|March 15, 2011
PubMed

Insights

Echocardiography can identify specific features of apical hypertrophic cardiomyopathy (ApHCM) linked to worse outcomes. Detecting cavity obliteration and paradoxical flow helps predict cardiovascular events in ApHCM patients.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Apical hypertrophic cardiomyopathy (ApHCM) can lead to apical asynergy, including sequestration or aneurysm.
  • These echocardiographic findings may correlate with adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the association between echocardiographic parameters and morphological patterns of left ventriculograms with cardiovascular morbidity and mortality in ApHCM patients.

Main Methods:

  • A cohort of 47 ApHCM patients was followed for 35.4 months.
  • Echocardiographic measurements included hypertrophy extent/degree, cavity obliteration, and paradoxical diastolic jet flow.
  • Left ventriculograms were analyzed for morphological abnormalities; cardiac catheterization was performed when consent was obtained.

Main Results:

  • Of 47 patients, 30 had pure ApHCM and 17 had mixed ApHCM. Sustained cavity obliteration was observed in 28 patients, with 17 showing paradoxical flow.
  • Left ventriculograms revealed "ace-of-spades" (15/31), apical sequestration (12/31), and apical aneurysm (4/31).
  • Cardiovascular morbidities (21/47 patients) were linked to mixed ApHCM, cavity obliteration, and paradoxical flow. Three of four deaths were associated with apical aneurysm.

Conclusions:

  • Echocardiography is crucial for detecting cavity obliteration and paradoxical flow in ApHCM.
  • Differentiating pure from mixed ApHCM forms and identifying apical sequestration versus aneurysm via echocardiography is clinically important.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...